| Product Code: ETC6176031 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Breast Cancer Liquid Biopsy Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Breast Cancer Liquid Biopsy Market - Industry Life Cycle |
3.4 Australia Breast Cancer Liquid Biopsy Market - Porter's Five Forces |
3.5 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Circulating Biomarkers, 2021 & 2031F |
3.7 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Australia Breast Cancer Liquid Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of breast cancer in Australia |
4.2.2 Growing adoption of liquid biopsy for early detection and monitoring of breast cancer |
4.2.3 Advancements in liquid biopsy technologies leading to improved accuracy and efficiency |
4.3 Market Restraints |
4.3.1 High cost associated with liquid biopsy tests |
4.3.2 Limited reimbursement policies for liquid biopsy procedures in Australia |
4.3.3 Lack of awareness among patients and healthcare professionals about the benefits of liquid biopsy for breast cancer |
5 Australia Breast Cancer Liquid Biopsy Market Trends |
6 Australia Breast Cancer Liquid Biopsy Market, By Types |
6.1 Australia Breast Cancer Liquid Biopsy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Kits, 2021- 2031F |
6.2 Australia Breast Cancer Liquid Biopsy Market, By Circulating Biomarkers |
6.2.1 Overview and Analysis |
6.2.2 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Extracellular Vesicles (EVs), 2021- 2031F |
6.2.3 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Cell-free DNA (cfDNA), 2021- 2031F |
6.2.4 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By ctRNA, 2021- 2031F |
6.2.5 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021- 2031F |
6.2.6 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By cfRNA, 2021- 2031F |
6.2.7 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Breast Cancer Liquid Biopsy Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.3 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Physician Laboratories, 2021- 2031F |
6.3.5 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Reference Laboratories, 2021- 2031F |
6.3.6 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Public Health Laboratories, 2021- 2031F |
6.3.7 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.3.8 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Pathology Laboratories, 2021- 2031F |
6.3.9 Australia Breast Cancer Liquid Biopsy Market Revenues & Volume, By Pathology Laboratories, 2021- 2031F |
7 Australia Breast Cancer Liquid Biopsy Market Import-Export Trade Statistics |
7.1 Australia Breast Cancer Liquid Biopsy Market Export to Major Countries |
7.2 Australia Breast Cancer Liquid Biopsy Market Imports from Major Countries |
8 Australia Breast Cancer Liquid Biopsy Market Key Performance Indicators |
8.1 Rate of adoption of liquid biopsy tests for breast cancer screening |
8.2 Number of research studies and clinical trials using liquid biopsy technologies in breast cancer |
8.3 Percentage of healthcare facilities offering liquid biopsy services for breast cancer detection and monitoring |
9 Australia Breast Cancer Liquid Biopsy Market - Opportunity Assessment |
9.1 Australia Breast Cancer Liquid Biopsy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Breast Cancer Liquid Biopsy Market Opportunity Assessment, By Circulating Biomarkers, 2021 & 2031F |
9.3 Australia Breast Cancer Liquid Biopsy Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Australia Breast Cancer Liquid Biopsy Market - Competitive Landscape |
10.1 Australia Breast Cancer Liquid Biopsy Market Revenue Share, By Companies, 2024 |
10.2 Australia Breast Cancer Liquid Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here